The Chief Executive Officer of the Saudi Food and Drug Authority (SFDA), H.E. Prof. Dr. Hisham S. Aljadhey, has extended his congratulations to the Custodian of the Two Holy Mosques, King Salman bin Abdulaziz Al Saud, and HRH Prince Mohammed bin Salman bin Abdulaziz, Crown Prince and Prime Minister, as well as to the Arab and Islamic nations, on the occasion of Eid al-Adha 1446 AH.
H.E. Mr. Fahad bin Abdulrahman Al-Jalajel, Minister of Health and Chairman of the Board of Directors of the Saudi Food and Drug Authority (SFDA), visited the SFDA’s Hajj Operations Centre in Makkah, where he was received by the Chief Executive Officer, H.E. Prof. Dr. Hisham S. Aljadhey.
During the visit, Mr. Al-Jalajel reviewed the efforts undertaken by the SFDA and the progress of its operations during the Hajj season, in line with the approved operational plan and its active contribution to ensuring the safety of food and drug products provided to pilgrims.
The Chief Executive Officer of the Saudi Food and Drug Authority (SFDA), H.E. Dr. Hisham S. Aljadhey, recently undertook a series of inspection visits to critical locations, food establishments, and control centers in Makkah and Jeddah. These visits were integral to the Authority's proactive measures for the upcoming 2025 Hajj season, focusing on evaluating operational readiness and ensuring field compliance.
The Chief Executive Officer of the Saudi Food and Drug Authority (SFDA), H.E. Dr. Hisham S. Aljadhey, today welcomed the President of the Saudi Data and Artificial Intelligence Authority (SDAIA), Dr. Abdullah Al Ghamdi, at the SFDA’s headquarters in Riyadh. The visit focused on strengthening collaboration and direct coordination to leverage data and artificial intelligence (AI) for business development in shared sectors.
During his official visit to the Arab Republic of Egypt, H.E. Prof. Dr. Hisham S. Aljadhey, Chief Executive Officer of the Saudi Food and Drug Authority (SFDA), held meetings with several officials in Cairo to strengthen bilateral cooperation and promote collaboration in areas of shared interest.
The Saudi Food and Drug Authority (SFDA) and the Jordan Food and Drug Administration (JFDA) today signed a Memorandum of Understanding (MoU) in Amman. The agreement aims to enhance regulatory integration between the two sides.
The signing ceremony was attended by H.E. Dr. Hisham S. Aljadhey, CEO of the SFDA, H.E. Dr. Nizar Mheidat, Director General of the JFDA, and Mr. Mohammed bin Hassan Mounis, Acting Chargé d’Affaires at the Saudi Arabia’s Embassy in Jordan.
The Chief Executive Officer of the Saudi Food and Drug Authority (SFDA), H.E. Dr. Hisham S. Aljadhey, conveyed his sincere congratulations to the Custodian of the Two Holy Mosques, King Salman bin Abdulaziz Al Saud, and H.R.H. Prince Mohammed bin Salman bin Abdulaziz, Crown Prince and Prime Minister – may God protect them – on the accomplishments highlighted in the 2024 annual report of Saudi Vision 2030.
The Saudi Food and Drug Authority (SFDA) and the French Agency for Food, Environmental and Occupational Health & Safety (ANSES) have signed a Memorandum of Understanding (MoU) focused on the management of veterinary medicinal products. The agreement aims to strengthen collaboration and facilitate the exchange of information and expertise between the two parties.
The signing took place in Paris, France, during the official visit of H.E. Mr. Fahad Abdulrahman AlJalajel, the Minister of Health of Saudi Arabia and Chairman of the SFDA Board of Directors.
The Saudi Food and Drug Authority (SFDA) hosted the Drug Innovation Conference, timed to coincide with World Creativity and Innovation Day. The event, held at the SFDA's headquarters in Riyadh, drew participation from officials representing government authorities, research centers, and universities.
The Saudi Food and Drug Authority (SFDA) has demonstrated remarkable growth, innovation, and a steadfast commitment to public health from 2017 to 2022. Aligning its strategies with Saudi Vision 2030, the SFDA has evolved into a more efficient and dynamic organization dedicated to operational excellence.
